Help Sitemap Home Skip Navigation Contact Us Disability Statement


Pain relief drug linked to heart attacks, claims study

Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image

Published Date: 04 September 2008
IBUPROFEN may raise the risk of heart attacks and other fatal and serious problems when elderly people take it daily for arthritis, US researchers claimed yesterday.
They said the popular over-the-counter pain reliever was the only drug in the class that includes aspirin and other analgesics to raise the risk of serious heart disease – along with the now-withdrawn Vioxx.

Dr Daniel Solomon of Brigham and Women's Hospital in Boston, who led the research, said: "Our findings suggest that rofecoxib and ibuprofen are the only agents consistently associated with an increased risk for cardiovascular disease events among specific subgroups.

"The fact that we did not observe a similar risk concentration among patients using many of the other agents may be of even greater relevance. These results should bolster physicians' and patients' confidence."



Page 1 of 1

  • Last Updated: 03 September 2008 11:35 PM
  • Source: The Scotsman
  • Location: Edinburgh
 
1

Charles Linskaill,

Edinburgh 04/09/2008 01:40:19

"IBUPROFEN" is and is known to be a dodgy 'Pain Killer'

This has been known for some time!

It also can cause miscarriage's, my DYW 'point-blank' wont take it for pain relief.

Far better the old Aspirin and newer paracetamol's!
2

Boy Wonder,

04/09/2008 07:38:43
Can we please have something to combat the pain Chuckles Linskaill inflicts on the reading public daily???

 

Comment on this Story

 

In order to post comments you must Register or Sign In

 
 
 
  

 
 


Sister Newspapers:
Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.